£4.5M
The Bristol based biotech startup secured £4.5m from Eos Advisory, Calculus Capital, and HERmesa to expand manufacturing and drive commercial validation.
E
EnsiliTech
EnsiliTech develops room temperature stabilisation technology for vaccines and biologics.
Bristol, UK
£5.7MTotal raised
EnsiliTech develops room temperature stabilisation technology for vaccines and biologics using silica shell encapsulation. The Bristol based biotech startup aims to eliminate cold chain dependency in pharmaceutical logistics.
Categories
Founders
AS
Asel Sartbaeva
CEO
Asel is co-founder and CEO of EnsiliTech and a Reader in Chemistry at the University of Bath. She brings academic research and technology commercialisation experience from roles at the University of Oxford and the University of Bath.
LinkedInAS
Asya Sartbaeva
CEO
Investors
- £4.5M
- £1.2M
Funding history
£1.2M
The pre-seed round was led by Science Angel Syndicate and Fink Family Office to develop cold chain-free vaccine technology.